Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes

This trial is studying whether starting automated insulin delivery (a closed-loop system that automatically adjusts insulin based on a continuous glucose sensor) early after a Type 1 Diabetes diagnosis in children and adolescents leads to better blood sugar control compared to standard approaches. **You may be eligible if...** - You are between 2 and 17.9 years old - You were diagnosed with Type 1 Diabetes at least 3 months ago but no more than 6 months ago - You have tested positive for at least one diabetes-related antibody - You are on multiple daily injections or an insulin pump - You and/or your parents have been trained in carbohydrate counting - You have a smartphone compatible with the Dexcom G6 app **You may NOT be eligible if...** - Your parent or guardian is unwilling to participate in insulin management decisions - You have another chronic disease or are on other medications affecting blood sugar - You are already using a hybrid closed-loop insulin delivery system - You have a skin allergy to device adhesives - You or your family have significant cognitive or psychological challenges affecting device management Talk to your doctor to see if this trial is right for you.